FDA Approves Gene Therapy for Hemophilia A

Severe cases of the bleeding disorder can be life-threatening. The U.S. Food and Drug Administration (FDA) has granted approval for Roctavian, gene therapy for adults with severe hemophilia…

Read More

Back to top
FE3